ZLAB

NASDAQ HEALTHCARE

Zai Lab Ltd

$23.58

-$0.76 (-3.12%)

Live quote

52w: $15.96 – $27.50

Loading chart…

P/E Ratio—

P/B Ratio45.01

EV/EBITDA—

Debt/Equity—

ROE-28.92%

ROIC—

Revenue Growth15.33%

Gross Margin0.02%

Zai Lab Limited, a biopharmaceutical company, discovers, licenses, develops and markets therapies to treat cancer, autoimmune and infectious diseases in China. The company is headquartered in Shanghai, China.

Own ZLAB? Track it here.

Create a free account to add ZLAB to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account